This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 May 22;370(21):2048.

doi: 10.1056/NEJMc1403303.

Bevacizumab for newly diagnosed glioblastoma

Ian E Haines, George L Gabor Miklos

PMID: 24849089
DOI: 10.1056/NEJMc1403303

Comment

Bevacizumab for newly diagnosed glioblastoma

Ian E Haines et al. N Engl J Med. 2014.

. 2014 May 22;370(21):2048.

doi: 10.1056/NEJMc1403303.

Authors

Ian E Haines, George L Gabor Miklos

PMID: 24849089
DOI: 10.1056/NEJMc1403303

No abstract available

PubMed Disclaimer

Comment in

Bevacizumab for newly diagnosed glioblastoma.
Gilbert MR, Sulman EP, Mehta MP. Gilbert MR, et al. N Engl J Med. 2014 May 22;370(21):2048-9. doi: 10.1056/NEJMc1403303. N Engl J Med. 2014. PMID: 24849088 No abstract available.
Bevacizumab for newly diagnosed glioblastoma.
Chinot OL, Wick W, Cloughesy T. Chinot OL, et al. N Engl J Med. 2014 May 22;370(21):2049. doi: 10.1056/NEJMc1403303. N Engl J Med. 2014. PMID: 24860870 No abstract available.

Comment on

A randomized trial of bevacizumab for newly diagnosed glioblastoma.
Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S, Won M, Jeraj R, Brown PD, Jaeckle KA, Schiff D, Stieber VW, Brachman DG, Werner-Wasik M, Tremont-Lukats IW, Sulman EP, Aldape KD, Curran WJ Jr, Mehta MP. Gilbert MR, et al. N Engl J Med. 2014 Feb 20;370(8):699-708. doi: 10.1056/NEJMoa1308573. N Engl J Med. 2014. PMID: 24552317 Free PMC article. Clinical Trial.
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.
Chinot OL, Wick W, Mason W, Henriksson R, Saran F, Nishikawa R, Carpentier AF, Hoang-Xuan K, Kavan P, Cernea D, Brandes AA, Hilton M, Abrey L, Cloughesy T. Chinot OL, et al. N Engl J Med. 2014 Feb 20;370(8):709-22. doi: 10.1056/NEJMoa1308345. N Engl J Med. 2014. PMID: 24552318 Clinical Trial.

Similar articles

Bevacizumab for newly diagnosed glioblastoma.
Chinot OL, Wick W, Cloughesy T. Chinot OL, et al. N Engl J Med. 2014 May 22;370(21):2049. doi: 10.1056/NEJMc1403303. N Engl J Med. 2014. PMID: 24860870 No abstract available.
Bevacizumab in glioblastoma--still much to learn.
Fine HA. Fine HA. N Engl J Med. 2014 Feb 20;370(8):764-5. doi: 10.1056/NEJMe1313309. N Engl J Med. 2014. PMID: 24552324 No abstract available.
Neuro-oncology: Bevacizumab prolongs progression-free survival but not overall survival in newly diagnosed glioblastoma.
Malkki H. Malkki H. Nat Rev Neurol. 2014 Apr;10(4):179. doi: 10.1038/nrneurol.2014.47. Epub 2014 Mar 18. Nat Rev Neurol. 2014. PMID: 24638136 No abstract available.
Bevacizumab and glioblastoma: scientific review, newly reported updates, and ongoing controversies.
Field KM, Jordan JT, Wen PY, Rosenthal MA, Reardon DA. Field KM, et al. Cancer. 2015 Apr 1;121(7):997-1007. doi: 10.1002/cncr.28935. Epub 2014 Sep 26. Cancer. 2015. PMID: 25263092 Review.
Bevacizumab and other targeted agents in the upfront treatment of glioblastoma.
Clarke JL. Clarke JL. Semin Radiat Oncol. 2014 Oct;24(4):273-8. doi: 10.1016/j.semradonc.2014.06.002. Semin Radiat Oncol. 2014. PMID: 25219812 Review.

See all similar articles

Cited by

Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?
Chiocca EA, Nassiri F, Wang J, Peruzzi P, Zadeh G. Chiocca EA, et al. Neuro Oncol. 2019 Jan 1;21(1):14-25. doi: 10.1093/neuonc/noy170. Neuro Oncol. 2019. PMID: 30346600 Free PMC article. Review.
Tumor Microenvironment and Microvascular Density in Human Glioblastoma.
Tamma R, Ingravallo G, Annese T, d'Amati A, Lorusso L, Ribatti D. Tamma R, et al. Cells. 2022 Dec 20;12(1):11. doi: 10.3390/cells12010011. Cells. 2022. PMID: 36611806 Free PMC article.
Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
Shields LB, Shelton BJ, Shearer AJ, Chen L, Sun DA, Parsons S, Bourne TD, LaRocca R, Spalding AC. Shields LB, et al. Radiat Oncol. 2015 Oct 31;10:222. doi: 10.1186/s13014-015-0527-0. Radiat Oncol. 2015. PMID: 26520780 Free PMC article.
Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy.
Qi Z, Long X, Liu J, Cheng P. Qi Z, et al. Front Cell Neurosci. 2022 Sep 9;16:819363. doi: 10.3389/fncel.2022.819363. eCollection 2022. Front Cell Neurosci. 2022. PMID: 36159398 Free PMC article. Review.
Melatonin's Antineoplastic Potential Against Glioblastoma.
Moretti E, Favero G, Rodella LF, Rezzani R. Moretti E, et al. Cells. 2020 Mar 3;9(3):599. doi: 10.3390/cells9030599. Cells. 2020. PMID: 32138190 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information